Date
Aug 7, 2021 7:00 PM — 8:30 PM
Event
Medscape Live
Location
JW Marriott
510 Water Street, Tampa, Florida, 02114, United States
Overview & Learning Objectives
- Review the burden of keratinocyte carcinomas (KCC)
- Recognize advances in risk stratification of patients with keratinocyte carcinoma
- Discuss recently approved therapeutic strategies in CSCC, including the use of Immune Checkpoint Inhibitors as primary treatment for advanced disease, as well as emerging strategies in the neo-adjuvant and adjuvant setting
- Review the recent evidence demonstrating activity of Immune Checkpoint Inhibitors for Basal Cell Carcinoma
This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement
David Michael Miller
Medical Oncologist and Dermatologist
My research interests include clinical and translational research in advanced skin cancers.